Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Stocks To Watch: Teladoc Health Sees Relative Strength Rating Jump To 89

When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. Teladoc Health is one stock that just reached the mark, now earning a score of 89.

IBD's proprietary RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.

Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an RS Rating of at least 80 as they begin their biggest price moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Teladoc Health has moved more than 5% past a 12.43 entry in a first-stage cup without handle, meaning it's now out of a proper buy zone. Look for the stock to create a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week line.

Teladoc Health posted negative growth for both sales and earnings last quarter. Teladoc Health is expected to release its next quarterly numbers on or around Feb. 26.

The company earns the No. 7 rank among its peers in the Computer Software-Medical industry group. Doximity, Waystar Holding and Veeva Systems Cl A are among the top 5 highly rated stocks within the group.

RELATED:

Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.